PVLA
NASDAQStockPalvella Therapeutics, Inc.
$124.50-12.10 (-8.86%)
52-Week Range
$19.87
$148.34
Key Stats
Market Cap
1.5B
P/E Ratio
—
Dividend Yield
—
Beta
-0.29
Volume
384.3K
Avg Volume
385.8K
Performance
1M
+67.53%
3M
+53.52%
6M
+150.60%
YTD
+36.22%
1Y
+396.73%
3Y
+964.69%
5Y
+964.69%
Price Chart
ETF Exposure
PVLA is held by 74 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| SPYI.DE | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About PVLA ETF Exposure
Palvella Therapeutics, Inc. (PVLA) is held by 74 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, PVLA is a widely held institutional stock. The stock currently trades at $124.50. Investors can gain exposure to PVLA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PVLA, sorted by portfolio weight.